• Russ Biagio Altman, M.D., Ph.D.

    Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science, and (by courtesy) Computer Science, Stanford University

  • David W. Bates, M.D., M.Sc.

    Chief, Division of General Internal Medicine, Brigham and Women’s Hospital
    Co-Director, Program in Clinical Effectiveness, Harvard School of Public Health
    Medical Director, Clinical and Quality Analysis for Partners Healthcare
    Professor of Medicine, Harvard Medical School
    Professor of Health Policy and Management, Harvard School of Public Health

  • Kevin P. Campbell, Ph.D.

    Investigator, Howard Hughes Medical Institute
    Department Executive Officer, Molecular Physiology and Biophysics
    Roy J. and Lucille A. Carver Biomedical Research Chair, Molecular Physiology and Biophysics
    Professor, Neurology
    Director, Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (MDCRC)

  • Thomas R. Cech, Ph.D.

    Distinguished Professor, University of Colorado-Boulder
    Director, University of Colorado Biofrontiers Institute
    Investigator, Howard Hughes Medical Institute

  • Thomas O. Daniel, M.D.

    Founding Executive Director, Catalysis Advisors
    Former President of Research and Early Development, Celgene Corporation

  • David Glazer

    Engineering Director, Verily



  • Ann Graybiel, Ph.D.

    Institute Professor, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology
    Principal Investigator, McGovern Institute for Brain Research, Massachusetts Institute of Technology

  • William N. Hait, M.D., Ph.D.

    Global Head, Research and Development, Janssen, Pharmaceutical Companies of Johnson & Johnson

  • William G. Kaelin, Jr., M.D.

    Professor of Medicine, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School
    Investigator, Howard Hughes Medical Institute
    Associate Director, Basic Science, Dana-Farber Cancer Institute/Harvard Cancer Center

  • Mark T. Keating, M.D.

    President and CEO, Cambridge Therapeutics, Cambridge, MA
    Former Vice President and Global Head of Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Inc.

  • Michael A. Marletta, Ph.D.

    CH and Annie Li Chair in the Molecular Biology of Diseases
    Department of Chemistry
    Department of Molecular and Cell Biology
    University of California, Berkeley

  • Olufunmilayo I Olopade, M.D., F.A.C.P., O.O.N.

    Walter L. Palmer Distinguished Service Professor of Medicine and Human Genetics, University of Chicago
    Associate Dean of Global Health, University of Chicago
    Director, Center for Clinical Cancer Genetics, University of Chicago

  • Neil R. Powe, M.D., M.P.H., M.B.A.

    Constance B. Wofsy Distinguished Professor of Medicine
    Vice-Chairman, Department of Medicine, University of California San Francisco
    Chief of Medicine, San Francisco General Hospital
    Professor of Medicine, University of California San Francisco

  • Susan S. Taylor, Ph.D.

    Distinguished Professor, Department of Chemistry & Biochemistry, Department of Pharmacology (University of California, San Diego)